Seattle Gummy Company is a specialty pharmaceutical company focusing on delivering activpharmaceutical ingredients (APIs) using innovative gummy (semi-solid chewable gel) formulaChewable gummy formulation is a perfect carrier for delivering medications, especially for populations having problem swallowing pills and capsules, a condition affecting 30% of the population. SGC’ gummy drugs could significantly improve medication efficiency and patiencompliance. Building upon its proprietary API-Complexing and diabetic safe gummy technolprotected by a large IP portfolio, SGC has developed great tasting gummy drugs treating man diseases. With the initial focus on pediatric and geriatric markets, SGC’s drug development program features gummy drugs for treating allergy, pain, fever, cough, nausea, insomnia, inflammatory, cardiovascular conditions, and bacterial infection. The company has a divergummy drug pipeline in FDA approval process and has received the FDA approval for the IND very first gummy drug formulation in the world.